Vaping Side Effects You Should Know About
What the evidence actually links to vaping, separated from what it doesn't.
Vaping is newer than cigarettes by about a century, which means the evidence on what it does to you is thinner, shorter-term and harder to separate from what cigarettes did to people who used both. This is not a reason to assume vaping is fine; it is a reason to read the evidence carefully and pay attention to what it actually measured.
Respiratory effects
The best-documented side effects are respiratory. Throat irritation, coughing and shortness of breath are reported more frequently by vapers than by non-users in population surveys [1]. In clinical studies, vaping acutely increases airway resistance and causes measurable inflammation markers in some users [5].
The degree of irritation correlates with device power and nicotine concentration: high-wattage sub-ohm devices and high-nicotine salt pods tend to produce more respiratory symptoms than lower-powered devices [1]. This is relevant if you are currently vaping and experiencing symptoms, because it means the specific device matters.
The respiratory effects also differ by inhalation style. Pod devices, which are mouth-to-lung, deposit aerosol primarily in the upper airways. Sub-ohm devices, inhaled directly to the lungs, deliver aerosol deeper into the respiratory tree. The deeper the deposition, the more sensitive the tissue it contacts. A sub-ohm user coughing after a hit is experiencing irritation in tissue that is not designed to process anything other than clean air.
What the evidence does not yet show is whether long-term exclusive vaping causes chronic obstructive lung disease in the way cigarette smoking does. The longitudinal data does not exist yet; widespread pod vaping is barely a decade old. What does exist is evidence that the acute effects are real, measurable, and proportional to the intensity of use.
Cardiovascular markers
Nicotine is a cardiovascular stimulant regardless of how it arrives. Vaping acutely raises heart rate and blood pressure, and some studies show short-term changes in vascular stiffness and endothelial function [3] [6]. These are plausible markers of cardiovascular risk, but they are not the same as established long-term outcomes like heart attack or stroke.
The frequency of dosing amplifies the cardiovascular effect. A heavy vaper may take hundreds of hits per day, each producing a small spike in heart rate and blood pressure. The cardiovascular system is being stimulated, partially recovering, and stimulated again on a cycle that repeats throughout waking hours. The heart is never fully at its resting baseline during the day.
Habitual e-cigarette users show increased cardiac sympathetic activity (the fight-or-flight nervous system running chronically elevated) and higher markers of oxidative stress compared to non-users [6]. Oxidative stress is one of the mechanisms in the development of atherosclerosis, the buildup of plaques in arteries. This does not mean vaping causes heart attacks; it means one of the pathways that leads to cardiovascular disease is measurably more active in regular vapers.
The gap between short-term markers and long-term outcomes is real. It is also the gap that worries researchers most, because the direction of the short-term effects is consistent with elevated risk [6]. It is accurate to say that vaping is probably not cardiovascular-neutral, and premature to say how much risk it carries at population level.
Oral health
Dry mouth is one of the most common complaints from vapers, and it is not trivial. Propylene glycol, one of the two base liquids in most e-liquids, is hygroscopic: it pulls moisture from the mucous membranes of the mouth. Chronic dry mouth increases the risk of cavities and gum disease because saliva is a primary defense against both [1].
Nicotine adds a separate layer: it constricts blood vessels in the gums, reducing blood flow and impairing the local immune response. This vasoconstriction also masks early signs of gum disease by reducing the bleeding that would otherwise signal inflammation. A vaper can have inflamed gums that look calm and do not bleed, which means early periodontal problems progress further before they are noticed.
The bacterial population in the mouth shifts in vapers toward species associated with gum disease. The combination of dry mouth, reduced immune function, and bacterial changes creates a consistent tilt toward oral health problems that develops slowly and shows up late.
Headaches and dehydration
Headaches are frequently reported by vapers, particularly those using high-nicotine devices. The mechanism is likely a combination of nicotine’s vasoconstrictive effects and the dehydrating action of propylene glycol. When both are operating simultaneously, the headache pattern is consistent: it comes on during or shortly after a heavy vaping session and is partially relieved by hydration.
For some users, headaches are the first sign of excessive nicotine intake. A single 5% pod hit delivers a significant dose. In users who were previously using lower-nicotine devices or who recently started, the vasoconstrictive headache is the body’s way of saying the dose is higher than the cardiovascular system would like.
Nicotine-specific effects
Many of the side effects of vaping are not specific to the aerosol; they are specific to nicotine. Nicotine suppresses appetite, raises resting metabolic rate slightly, and disrupts sleep architecture. These are pharmacological effects that occur regardless of delivery method.
The appetite suppression is one that users often do not recognize as a side effect because it functions as a perceived benefit. Nicotine reduces the frequency and intensity of hunger signals, which can alter eating patterns without the user making a conscious dietary change. When they quit, the appetite returns to its natural level, and the resulting weight gain is often misattributed to quitting being “unhealthy” rather than to the restoration of normal appetite.
The sleep disruption is among the most consequential and least recognized. Nicotine is a stimulant. It reduces slow-wave (deep) sleep and, in dependent users, causes micro-awakenings during the night as blood nicotine drops and withdrawal begins. The cumulative effect is chronic sleep deprivation that the user attributes to stress, lifestyle, or getting older rather than to the device.
EVALI: the 2019 outbreak
In 2019, a wave of severe lung injuries in vapers prompted the term EVALI (e-cigarette or vaping product use-associated lung injury). The CDC investigation identified vitamin E acetate, a thickening agent used in illicit THC cartridges, as the primary cause [4]. The compound was found in the lung fluid of 94% of EVALI patients tested.
EVALI is worth understanding, but it is important to note that the cause was specific: an additive in illicit THC products, not standard nicotine e-liquid. The number of cases dropped sharply once the cause was identified and illicit cartridge use declined. The lesson from EVALI is about unregulated products and the importance of knowing what is in your device, not about nicotine vaping specifically.
What remains uncertain
The honest answer to “how bad is vaping for you?” is that the evidence is still accumulating. Short-term respiratory and cardiovascular effects are real and measurable. Long-term risk, particularly cancer risk, is not yet quantifiable because the exposure history in the population is too short. Comparisons to cigarettes consistently find that vaping produces fewer toxicants at lower levels [2], but “less harmful than cigarettes” is a low bar and not the same as “safe.”
The cancer question is the one that will take the longest to answer. Carcinogenesis typically requires decades of exposure before outcomes are measurable at population level. E-cigarette aerosol does contain some carcinogenic compounds (formaldehyde, acrolein, nitrosamines) at levels lower than cigarette smoke [1]. Whether those levels, sustained over 20 or 30 years of daily use, translate into elevated cancer risk is currently unknown. The compounds are there; the dose-time exposure data is not.
What we do know is that every side effect listed above, the respiratory irritation, the cardiovascular stimulation, the oral health changes, the sleep disruption, the headaches, improves or resolves after quitting. The side effects are real but they are not permanent, and the evidence for recovery after cessation is consistent across every system studied.
The timeline for recovery varies by system. Respiratory symptoms tend to improve within a few weeks, though some people experience a temporary increase in coughing as the cilia in the airways recover their function and begin clearing accumulated mucus. Cardiovascular markers such as resting heart rate and blood pressure normalize over days to weeks. Sleep architecture takes longer to fully recover because the brain needs time to recalibrate its neurotransmitter systems after chronic nicotine exposure, but most people notice meaningful improvement within the first month. Oral health changes, particularly dry mouth, resolve relatively quickly, while gum tissue recovery takes longer and depends on whether periodontal disease was already established.
If you are vaping and not planning to quit, the evidence supports using lower-nicotine liquids and lower-powered devices to minimize exposure. If you are planning to quit, the side effects described here are another reason to follow through, and the evidence on how to do that effectively is covered elsewhere on this site.
One thing worth noting: many of these side effects develop gradually enough that they become the new normal. The chronic dry mouth, the slightly elevated resting heart rate, the poor sleep, the persistent throat irritation. They accumulate slowly enough that you adjust to each one rather than noticing it as a problem. People who quit often report being surprised by how much better they feel in ways they had stopped noticing were wrong. The cough clears. Sleep deepens. The persistent low-grade sore throat disappears. The headaches stop. Each of these on its own seems minor. Together, they represent a meaningful improvement in how you feel day to day, and most people do not fully appreciate the cumulative burden until it lifts.
If you’d like support quitting, the Quitline (1-800-QUIT-NOW in the US) and smokefree.gov have free resources. Your doctor or pharmacist can also advise on NRT.
Frequently asked questions
What are the most common side effects of vaping?
Throat irritation, coughing, dry mouth and headache are the most frequently reported. Respiratory symptoms are more common with high-nicotine and high-wattage devices.
Does vaping cause lung damage?
Vaping causes measurable airway inflammation in some users and is associated with increased respiratory symptoms. EVALI (e-cigarette or vaping product use-associated lung injury) was linked primarily to vitamin E acetate in illicit THC cartridges, not standard nicotine e-liquids.
Does vaping affect your heart?
Nicotine from vaping acutely raises heart rate and blood pressure. Some studies show short-term effects on vascular function. Long-term cardiovascular outcomes are not yet established in prospective trials.
Are vaping side effects reversible?
Many short-term effects, particularly coughing and throat irritation, tend to resolve after quitting. Long-term reversibility depends on duration and intensity of use, and on whether there is an underlying condition.
Sources and further reading
- Gotts JE et al. — What are the respiratory effects of e-cigarettes?
BMJ, 2019, narrative review of respiratory effects of e-cigarette use. DOI: 10.1136/bmj.l5275
- Bhatta DN, Glantz SA — Association of e-cigarette use with respiratory disease among adults
American Journal of Medicine, 2020, cross-sectional analysis of BRFSS data, n=705,159. DOI: 10.1016/j.amjmed.2019.12.005
- Qasim H et al. — Impact of electronic cigarettes on the cardiovascular system
Journal of the American Heart Association, 2020, review of cardiovascular effects. DOI: 10.1161/JAHA.119.014077
- Blount BC et al. — Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI
NEJM, 2020, 51 EVALI patients, vitamin E acetate found in 94% of BAL samples. DOI: 10.1056/NEJMoa1916433
- Wills TA et al. — E-cigarette use and respiratory disorders: an integrative review
Preventive Medicine, 2021, integrative review of respiratory outcomes. DOI: 10.1016/j.ypmed.2020.106321
- Benowitz NL, Fraiman JB — Cardiovascular effects of electronic cigarettes
Nature Reviews Cardiology, 2022, review of cardiovascular evidence. DOI: 10.1038/s41569-021-00648-y
Sources checked May 28, 2025. This is an editorial summary, not a systematic review or individual advice.